COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Research output: Contribution to journalArticlepeer-review


  • CARE-MG Study Group

Colleges, School and Institutes

External organisations

  • Stanford University
  • University of Durham
  • Queen Elizabeth Hospital
  • Harvard University
  • Northwestern University
  • George Washington University
  • North Carolina State University
  • University of Alabama
  • University Hospital Münster
  • Hospital de la Santa Creu I Sant Pau
  • Istituto Neurologico Carlo Besta
  • International University of Health and Welfare
  • Hanamaki General Hospital
  • Haskins Laboratories New Haven


Original languageEnglish
Pages (from-to)970-971
Number of pages2
JournalThe Lancet Neurology
Issue number12
Publication statusPublished - Dec 2020


  • COVID-19/diagnosis, Humans, Myasthenia Gravis/diagnosis, Registries, Risk Factors, SARS-CoV-2